Bank of New York Mellon’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.1K Hold
22,267
﹤0.01% 4105
2025
Q1
$14.6K Hold
22,267
﹤0.01% 4076
2024
Q4
$22.7K Buy
22,267
+7,757
+53% +$7.91K ﹤0.01% 4079
2024
Q3
$12.6K Hold
14,510
﹤0.01% 4066
2024
Q2
$5.2K Sell
14,510
-458,602
-97% -$164K ﹤0.01% 4104
2024
Q1
$317K Sell
473,112
-23,276
-5% -$15.6K ﹤0.01% 3748
2023
Q4
$270K Sell
496,388
-4,953
-1% -$2.69K ﹤0.01% 3838
2023
Q3
$301K Sell
501,341
-8,499
-2% -$5.1K ﹤0.01% 3793
2023
Q2
$663K Buy
509,840
+9,708
+2% +$12.6K ﹤0.01% 3436
2023
Q1
$880K Buy
500,132
+1,998
+0.4% +$3.52K ﹤0.01% 3188
2022
Q4
$1.56M Sell
498,134
-15,359
-3% -$48.2K ﹤0.01% 2973
2022
Q3
$2.52M Buy
513,493
+51,585
+11% +$253K ﹤0.01% 2691
2022
Q2
$1.91M Buy
461,908
+18,718
+4% +$77.5K ﹤0.01% 2851
2022
Q1
$2.58M Buy
443,190
+4,035
+0.9% +$23.5K ﹤0.01% 2799
2021
Q4
$3.29M Buy
439,155
+3,058
+0.7% +$22.9K ﹤0.01% 2688
2021
Q3
$3.93M Buy
436,097
+31,274
+8% +$282K ﹤0.01% 2603
2021
Q2
$4.85M Sell
404,823
-85,063
-17% -$1.02M ﹤0.01% 2505
2021
Q1
$6.14M Sell
489,886
-18,616
-4% -$233K ﹤0.01% 2352
2020
Q4
$7.94M Sell
508,502
-20,449
-4% -$319K ﹤0.01% 2124
2020
Q3
$5M Sell
528,951
-14,534
-3% -$137K ﹤0.01% 2217
2020
Q2
$4.87M Buy
543,485
+28,840
+6% +$258K ﹤0.01% 2218
2020
Q1
$3.28M Buy
514,645
+5,858
+1% +$37.3K ﹤0.01% 2287
2019
Q4
$4.26M Sell
508,787
-3,094
-0.6% -$25.9K ﹤0.01% 2412
2019
Q3
$4.63M Buy
511,881
+6,625
+1% +$60K ﹤0.01% 2319
2019
Q2
$5.44M Buy
505,256
+35,809
+8% +$386K ﹤0.01% 2287
2019
Q1
$4.48M Buy
469,447
+5,802
+1% +$55.3K ﹤0.01% 2383
2018
Q4
$5.32M Buy
463,645
+8,910
+2% +$102K ﹤0.01% 2250
2018
Q3
$7.71M Buy
454,735
+7,472
+2% +$127K ﹤0.01% 2177
2018
Q2
$6.35M Sell
447,263
-16,585
-4% -$236K ﹤0.01% 2265
2018
Q1
$8.81M Buy
463,848
+71,135
+18% +$1.35M ﹤0.01% 2042
2017
Q4
$6.44M Buy
392,713
+18,404
+5% +$302K ﹤0.01% 2224
2017
Q3
$5.61M Buy
374,309
+34,467
+10% +$517K ﹤0.01% 2286
2017
Q2
$2.99M Buy
339,842
+6,537
+2% +$57.5K ﹤0.01% 2597
2017
Q1
$1.73M Buy
333,305
+19,142
+6% +$99.5K ﹤0.01% 2924
2016
Q4
$958K Sell
314,163
-78
-0% -$238 ﹤0.01% 3283
2016
Q3
$1.46M Sell
314,241
-3,022,300
-91% -$14M ﹤0.01% 2964
2016
Q2
$19.3M Sell
3,336,541
-22,790
-0.7% -$132K 0.01% 1426
2016
Q1
$20.3M Buy
3,359,331
+1,466,593
+77% +$8.87M 0.01% 1399
2015
Q4
$17.3M Sell
1,892,738
-54,885
-3% -$501K 0.01% 1480
2015
Q3
$11M Buy
1,947,623
+67,696
+4% +$382K ﹤0.01% 1808
2015
Q2
$20.8M Buy
1,879,927
+105,856
+6% +$1.17M 0.01% 1462
2015
Q1
$27.8M Buy
1,774,071
+206,179
+13% +$3.23M 0.01% 1258
2014
Q4
$23.8M Buy
1,567,892
+1,201,578
+328% +$18.3M 0.01% 1337
2014
Q3
$3.95M Sell
366,314
-2,682
-0.7% -$28.9K ﹤0.01% 2457
2014
Q2
$5.64M Buy
368,996
+19,106
+5% +$292K ﹤0.01% 2263
2014
Q1
$6.33M Buy
349,890
+32,077
+10% +$580K ﹤0.01% 2183
2013
Q4
$4.42M Buy
317,813
+37,308
+13% +$518K ﹤0.01% 2375
2013
Q3
$2.94M Buy
280,505
+18,853
+7% +$198K ﹤0.01% 2582
2013
Q2
$2.04M Buy
+261,652
New +$2.04M ﹤0.01% 2775